HPM’s Larry Houck Is Speaking at Opioid and Fentanyl Abuse Management Summit

Controlled substances are critical to patient care, but hospitals have always been vulnerable to their diversion by trusted employees.  In a number of recent cases, employees have been able to divert considerable quantities of controlled substances undetected over extended periods of time.  These incidents resulted in overdoses and deaths, patient undertreatment, multimillion-dollar civil monetary penalties, and comprehensive remedial settlements.  The Drug Enforcement Administration asserted that the hospitals’ noncompliance with mandatory recordkeeping, reporting, and security requirements enabled the diversion.

Larry Houck ‘s presentation, “Hospital/Healthcare Facility Controlled Substance Diversion: Recent Case Studies,” focuses on several of those high-profile cases and discusses how hospitals can prevent and detect employee diversion of controlled substances. The presentation on this timely topic, at the World Conference Forum’s 2026 Opioid & Fentanyl Abuse Management Summit in Chicago on July 20th-21st.

Mr. Houck will present on:

• How employees in several high-profile cases diverted significant controlled substance quantities;
• Red flags the hospitals missed;
• Safeguards for minimizing internal diversion risks; and
• Best practices for maximizing diversion detection.

Click here for information about WCF’s Opioid & Abuse Management Summit.